Novo Nordisk has agreed to acquire Cardior for up to 1.025 billion Euros, including an upfront payment and additional payments if certain development and...
The U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease Designation (RPDD) to LSTA1, Lisata Therapeutics’ lead product candidate, for the treatment...
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has signed an agreement to acquire the Genentech large-scale biologics manufacturing site...